Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon

African Health Sciences

Volumn 6, Issue 4, 2006, Pages 232-235

  Gangoue Pieboji, Jospeh ^a,b   Koulla Shiro, Sinata ^b   Ngassam, Pierre ^b   Adiogo, Dieudonne ^b   Ndumbe, Peter ^b  

^a Institute of Medical Research and Medicinal Plant Studies   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Antimicrobial agents; Bacteria susceptibility testing; Cameroon; Gram negative bacilli; Resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; OFLOXACIN; PIPERACILLIN; TOBRAMYCIN;

ACTINOBACTERIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BLOOD ANALYSIS; CAMEROON; CITROBACTER; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL LABORATORY; IN VITRO STUDY; KLEBSIELLA; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PUS; URINALYSIS;

ANTI-INFECTIVE AGENTS; CAMEROON; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 34347394505     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997 Clin Infect Dis 1999; 29: 595-607.
2. Livermore DM. â-lactamases in laboratory and clinical resistance. Clin Microb Rev 1995; 8:557-584.
3. Gangoué-Piéboji J. Résistance des bacilles a gram-négatif aux antibiotiques: prévalence et caractérisation des âlactamases a spectre élargi a l'hopital Central de Yaoundé. Thèse de Doctorat de 3e cycle, Université de Yaoundé I, 2000: P 210.
4. Cosgrove SE, Kaye KS, Eliopoulos GM and Carmeli Y. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med 2002; 162: 185-190.
5. Wise R, Hart T, Cars O, Streuleus M, Helmut, Huovinen P. Antimicrobial resistance is a major threat to public health. British Med J 1998; 317: 609-610.
6. Shaes DM, Gerdin DN, John JF, Jr, Craig WA, Borstein DL, Ducan RA et al. Society for Healthcare Epidemiology of America and Infectious Diseases of America Committee on the prevention of antimicrobial resistance. Clin Infec Dis 1997; 25: 584-599.
7. Farmer II JJ, Kelly MT. Enterobacteriaceae. In Lenette EH, Balows A, Hausler WJ, Shadomy HJ (eds). Manual of clinical Microbiology. Washington DC: American Society for Microbiology; 1991, P. 360-383.
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2 A6 (M100-S7). Wagne, PA: NCCLS, 1997.
9. Gangoué-Piéboji J. Koulla-Shiro S, Ngassam P, Adiogo D, Njine T, Ndumbe P. Antimicrobial resistance of Gramnegative bacilli isolates form inpatients and outpatients at Yaounde Central Hospital, Cameroon. Inter J Infect Dis 2004; 8: 147-154.
10. Wenzel RP, Sahm DF, Thornsberry C, Draghi DC, Jones ME, Karlowsky JA. In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded spectrum cephalosporin and comparator antimicrobials: Implications for therapy. Antimicrob Agents Chemother 2003; 47: 3089-3098.
11. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS project. J Antimicrob Chemother 2003; 51: 69-76.
12. El Kholy A, Baseem H, Hall GS, Procop GW, Longworth DL. Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals. J Antimicrob Chemother 2003; 51:625-630.
13. Karlowsky JA, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Trends in antimicrobial susceptibilities among enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001. Antimicrob Agents Chemother 2003; 47: 1672-1680.
14. Lamikamra A, Ndep RB. Trimethoprim resistance in urinary tract pathogens in two Nigeria hospitals. J Antimicrob Chemother 1989; 23: 151-154.
15. Koulla-Shiro S, Boye CS, Dosso M, the members of the palm project. Surveillance of antimicrobial susceptibility of gram-negative pathogens responsible for nosocomial infections in West Africa (Abstract number E-95). San Diego, California: 42nd ICAAC; 1998, P 197.
16. Huovinen P, Sundström L, Swedberg G, Sköd O. Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother 1995; 39: 279-289.
17. Gales AC, Bolmstrom A, Sampaio J, Sader HS. Antimicrobial susceptibility of Klebsiella pneumoniae producing extended spectrum â-lactamase (ESBL) isolated in hospital in Brazil. Brazilian J Infec Dis 1997; 1:196-203.
18. Jones RN, Sader HS, Beach ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative gram-negative bacilli isolated in the SENTRY antimicrobial surveillance program (1997-2001). Inter J Antimicrob Agents 2003; 22:551-556.
19. Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States 1998 to 2001. Antimicrob Agents Chemother 2003; 47: 1681-1688.